Case number 1:20-cv-01763
Otsuka Pharmaceutical Co., Ltd. et al v. Zydus Pharmaceuticals (USA) Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 1, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:20-cv-01763-LPS, 446 in 1:19-cv-01938-LPS) STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Zydus). Signed by Judge Leonard P. Stark on 2/28/22. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01763-LPS (ntl) |
| Mar 1, 2022 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:19-cv-01938-LPS. (ntl) |
| Feb 28, 2022 | N/A | Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that in anticipation of reassignment of these cases to another judge, the parties shall meet and confer and, no later than tomorrow, March 1, submit a joint status report (one that collectively addresses all of these related cases), advising the Court of the following (in addition to anything else the parties wish to report): (i) how many and which patents are at issue in any of these cases; (ii) how many applications or how many filers are at issue, in total, across these cases; (iii) how many contested infringement allegations remain to be litigated; (iv) how many invalidity issues are to be litigated; (v) when do any applicable stays (e.g., 30-month stay) expire; (vi) how long do the parties anticipate the upcoming bench trial to be; and (vii) how important is it that trial occur on or around July 25, 2022, as currently scheduled? ORDERED by Judge Leonard P. Stark on 2/28/22. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01286-LPS, 1:20-cv-01763-LPS, 1:22-cv-00221-LPS (ntl) |
| Feb 25, 2022 | 15 | Stipulation (6) Docket Text: STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Zydus), by H. Lundbeck A/S, Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) |
| Jan 18, 2022 | 14 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.) and Expert Report of Christoph U. Correll, M.D. (Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew) |
| Mar 29, 2021 | 10 | Answer to Complaint (17) Docket Text: ANSWER to [1] Complaint, by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar) |
| Mar 29, 2021 | 11 | Disclosure Statement (4) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cadila Healthcare Ltd.. (Kraman, Pilar) |
| Mar 29, 2021 | 12 | Disclosure Statement (4) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cadila Healthcare Limited for Zydus Pharmaceuticals (USA) Inc. filed by Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) |
| Mar 29, 2021 | 13 | Redacted Document (5) Docket Text: REDACTED VERSION of [8] Stipulation by H. Lundbeck A/S, Otsuka Pharmaceutical Co.,Ltd. (Mayo, Andrew) |
| Mar 24, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] [SEALED] STIPULATION and Order Dismissing Defendant Zydus Healthcare (USA) LLC Without Prejudice and Amending Caption to Reflect Same -- Party Zydus Healthcare (USA) LLC. terminated. Signed by Judge Leonard P. Stark on 3/23/21. (ntl) |
| Mar 24, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] STIPULATION regarding waiver of service and March 29, 2021 deadline to respond to complaint filed by Otsuka Pharmaceutical Co.,Ltd, H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 3/23/21. (ntl) |
| Mar 22, 2021 | 9 | Stipulation (2) Docket Text: STIPULATION regarding waiver of service and March 29, 2021 deadline to respond to complaint, by H. Lundbeck A/S, Otsuka Pharmaceutical Co.,Ltd. (Mayo, Andrew) |
| Jan 14, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Denise Main, Erin M. Sommers, C. Collette Corser, Tyler B. Latcham for H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01287-LPS et al.(kmd) |
| Jan 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 1:20-cv-01365-LPS, 8 in 1:20-cv-01287-LPS, 13 in 1:20-cv-01296-LPS, 9 in 1:20-cv-01599-LPS, 7 in 1:20-cv-01428-LPS, 12 in 1:20-cv-01423-LPS, 11 in 1:20-cv-01335-LPS, 10 in 1:20-cv-01295-LPS, 7 in 1:20-cv-01581-LPS, 7 in 1:20-cv-01502-LPS, 7 in 1:20-cv-01763-LPS, 10 in 1:20-cv-01297-LPS, 11 in 1:20-cv-01332-LPS, 13 in 1:20-cv-01531-LPS) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham filed by Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 1/5/21. Associated Cases: 1:20-cv-01287-LPS et al. (ntl) |
| Dec 31, 2020 | 7 | Motion for Leave to Appear Pro Hac Vice (17) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. (Mayo, Andrew) |
| Dec 30, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Dec 23, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (apk) |
| Dec 23, 2020 | 1 | Main Document (13) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Cadila Healthcare Ltd., Zydus Healthcare (USA) LLC., Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3417702.) - filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Attachments: # (1) Exhibit A&B, # (2) Civil Cover Sheet)(apk) |
| Dec 23, 2020 | 1 | Exhibit A&B (60) |
| Dec 23, 2020 | 1 | Civil Cover Sheet (5) |
| Dec 23, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Dec 23, 2020 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/17/2020. Date of Expiration of Patent: 4/12/2026.Thirty Month Stay Deadline: 1/10/2023. (apk) |
| Dec 23, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE48,059. (apk) |
| Dec 23, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co.,Ltd. for Otsuka Pharmaceutical Co.,Ltd filed by Otsuka Pharmaceutical Co.,Ltd. (apk) |
| Dec 23, 2020 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (apk) |
| Dec 23, 2020 | 1 | Complaint* (1) |
